Divisions of General Internal Medicine and Infectious Diseases, Center for Research on Healthcare, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):231-237. doi: 10.1097/QAI.0000000000001998.
People living with HIV (PLWH) commonly report marijuana use for chronic pain, although there is limited empirical evidence to support its use. There is hope that marijuana may reduce prescription opioid use. Our objective was to investigate whether marijuana use among PLWH who have chronic pain is associated with changes in pain severity and prescribed opioid use (prescribed opioid initiation and discontinuation).
Participants completed self-report measures of chronic pain and marijuana use at an index visit and were followed up for 1 year in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS). Self-reported marijuana use was the exposure variable. Outcome variables were changes in pain and initiation or discontinuation of opioids during the study period. The relationship between exposure and outcomes was assessed using generalized linear models for pain and multivariable binary logistic regression models for opioid initiation/discontinuation.
Of 433 PLWH and chronic pain, 28% reported marijuana use in the past 3 months. Median pain severity at the index visit was 6.3/10 (interquartile range 4.7-8.0). Neither increases nor decreases in marijuana use were associated with changes in pain severity, and marijuana use was not associated with either lower odds of opioid initiation or higher odds of opioid discontinuation.
We did not find evidence that marijuana use in PLWH is associated with improved pain outcomes or reduced opioid prescribing. This suggests that caution is warranted when counseling PLWH about potential benefits of recreational or medical marijuana.
艾滋病毒感染者(PLWH)常报告为慢性疼痛而使用大麻,尽管支持其使用的经验证据有限。人们希望大麻可能会减少处方类阿片的使用。我们的目的是调查慢性疼痛的 PLWH 中使用大麻是否与疼痛严重程度和处方类阿片使用(开始和停止使用处方类阿片)的变化相关。
参与者在索引访问时完成了慢性疼痛和大麻使用的自我报告测量,并在艾滋病研究网络综合临床系统中心(CNICS)中进行了为期 1 年的随访。自我报告的大麻使用是暴露变量。研究期间的疼痛变化和阿片类药物的开始或停止是结果变量。使用广义线性模型评估暴露与疼痛之间的关系,使用多变量二项逻辑回归模型评估阿片类药物开始/停止的关系。
在 433 名艾滋病毒感染者和慢性疼痛患者中,28%的人报告在过去 3 个月内使用过大麻。索引访问时疼痛严重程度的中位数为 6.3/10(四分位距 4.7-8.0)。大麻使用的增加或减少与疼痛严重程度的变化均无关联,且大麻使用与较低的阿片类药物开始使用的几率或较高的阿片类药物停止使用的几率均无关。
我们没有发现证据表明,PLWH 使用大麻与改善疼痛结果或减少阿片类药物处方有关。这表明,在为 PLWH 提供关于娱乐性或医用大麻潜在益处的咨询时应谨慎。